A share price of Astria Therapeutics Inc [ATXS] is currently trading at $12.65, up 2.43%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ATXS shares have gain 13.55% over the last week, with a monthly amount glided 6.04%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Astria Therapeutics Inc [NASDAQ: ATXS] stock has seen the most recent analyst activity on July 29, 2024, when TD Cowen initiated its Buy rating and assigned the stock a price target of $35. Previously, Evercore ISI started tracking the stock with Outperform rating on March 28, 2023, and set its price target to $18.
Astria Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $4.26 and $16.90. Currently, Wall Street analysts expect the stock to reach $22.5 within the next 12 months. Astria Therapeutics Inc [NASDAQ: ATXS] shares were valued at $12.65 at the most recent close of the market. An investor can expect a potential return of 77.87% based on the average ATXS price forecast.
Analyzing the ATXS fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.25, Equity is -0.33 and Total Capital is -0.26. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 12.15 points at the first support level, and at 11.64 for the second support level. However, for the 1st resistance point, the stock is sitting at 13.04, and for the 2nd resistance point, it is at 13.42.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Astria Therapeutics Inc [NASDAQ:ATXS] is 21.87. Further, the Quick Ratio stands at 21.87, while the Cash Ratio is 5.34.
Transactions by insiders
Recent insider trading involved Morabito Christopher, Chief Medical Officer, that happened on Apr 01 ’24 when 10000.0 shares were sold. Director, PERCEPTIVE ADVISORS LLC completed a deal on Feb 01 ’24 to buy 2.48 million shares. Meanwhile, Chief Medical Officer Morabito Christopher sold 9200.0 shares on Jan 29 ’24.
